Literature DB >> 23125199

The pathogenesis and natural history of type 1 diabetes.

Mark A Atkinson1.   

Abstract

The purpose of this article is to provide an overview that summarizes much in the way of our current state of knowledge regarding the pathogenesis and natural history of type 1 diabetes in humans. This information is presented to the reader as a series of seminal historical discoveries that, when advanced through research, transformed our understanding of the roles for the immune system, genes, and environment in the formation of this disease. In addition, where longitudinal investigations of these three facets occurred, their roles within the development of type 1 diabetes, from birth to symptomatic onset and beyond, are discussed, including their most controversial elements. Having an understanding of this disorder's pathogenesis and natural history is key for attempts seeking to understand the issues of what causes type 1 diabetes, as well as to develop a means to prevent and cure the disorder.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23125199      PMCID: PMC3543105          DOI: 10.1101/cshperspect.a007641

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  123 in total

1.  Functional avidity directs T-cell fate in autoreactive CD4+ T cells.

Authors:  Roberto Mallone; Sharon A Kochik; Helena Reijonen; Bryan Carson; Steven F Ziegler; William W Kwok; Gerald T Nepom
Journal:  Blood       Date:  2005-07-19       Impact factor: 22.113

Review 2.  Update in type 1 diabetes.

Authors:  George S Eisenbarth
Journal:  J Clin Endocrinol Metab       Date:  2007-07       Impact factor: 5.958

Review 3.  Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis.

Authors:  G Dahlquist
Journal:  Diabetologia       Date:  2005-12-14       Impact factor: 10.122

4.  Low levels of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes.

Authors:  P Pozzilli; S Manfrini; A Crinò; A Picardi; C Leomanni; V Cherubini; L Valente; M Khazrai; N Visalli
Journal:  Horm Metab Res       Date:  2005-11       Impact factor: 2.936

5.  Sustained beta cell apoptosis in patients with long-standing type 1 diabetes: indirect evidence for islet regeneration?

Authors:  J J Meier; A Bhushan; A E Butler; R A Rizza; P C Butler
Journal:  Diabetologia       Date:  2005-10-05       Impact factor: 10.122

Review 6.  Environmental triggers and determinants of type 1 diabetes.

Authors:  Mikael Knip; Riitta Veijola; Suvi M Virtanen; Heikki Hyöty; Outi Vaarala; Hans K Akerblom
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

Review 7.  Is latent autoimmune diabetes in adults distinct from type 1 diabetes or just type 1 diabetes at an older age?

Authors:  Jerry P Palmer; Christiane S Hampe; Harvey Chiu; Amit Goel; Barbara M Brooks-Worrell
Journal:  Diabetes       Date:  2005-12       Impact factor: 9.461

8.  Incidence and trends of childhood Type 1 diabetes worldwide 1990-1999.

Authors: 
Journal:  Diabet Med       Date:  2006-08       Impact factor: 4.359

Review 9.  Dietary proteins as environmental modifiers of type 1 diabetes mellitus.

Authors:  David E Lefebvre; Karen L Powell; Alexander Strom; Fraser W Scott
Journal:  Annu Rev Nutr       Date:  2006       Impact factor: 11.848

10.  Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS).

Authors:  B Littorin; P Blom; A Schölin; H J Arnqvist; G Blohmé; J Bolinder; A Ekbom-Schnell; J W Eriksson; S Gudbjörnsdottir; L Nyström; J Ostman; G Sundkvist
Journal:  Diabetologia       Date:  2006-10-27       Impact factor: 10.122

View more
  85 in total

Review 1.  Mechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetes.

Authors:  Gabriella Fleixo-Lima; Hilla Ventura; Michal Medini; Liliana Bar; Pnina Strauss; Eli C Lewis
Journal:  J Diabetes Sci Technol       Date:  2014-08-25

2.  Considerations on the harvesting site and donor derivation for mesenchymal stem cells-based strategies for diabetes.

Authors:  L Zazzeroni; G Lanzoni; G Pasquinelli; C Ricordi
Journal:  CellR4 Repair Replace Regen Reprogram       Date:  2017-09-29

3.  Dynamic Immune Phenotypes of B and T Helper Cells Mark Distinct Stages of T1D Progression.

Authors:  Tania Habib; S Alice Long; Peter L Samuels; Archana Brahmandam; Megan Tatum; Andrew Funk; Anne M Hocking; Karen Cerosaletti; Michael T Mason; Elizabeth Whalen; David J Rawlings; Carla Greenbaum; Jane H Buckner
Journal:  Diabetes       Date:  2019-03-20       Impact factor: 9.461

Review 4.  Immune Mechanisms and Pathways Targeted in Type 1 Diabetes.

Authors:  Laura M Jacobsen; Brittney N Newby; Daniel J Perry; Amanda L Posgai; Michael J Haller; Todd M Brusko
Journal:  Curr Diab Rep       Date:  2018-08-30       Impact factor: 4.810

5.  Sensory nerve regeneration after epithelium wounding in normal and diabetic cornea.

Authors:  Fu-Shin Yu; Jia Yin; Patrick Lee; Frank S Hwang; Mark McDermott
Journal:  Expert Rev Ophthalmol       Date:  2015-06-26

6.  A Contrast in Pathogenic Responses between C57BL/6J and BALB/cJ Mice Using a Model of Retinal Injury.

Authors:  Haoshen Shi; Abdul S Ebrahim; Elizabeth A Berger
Journal:  Am J Pathol       Date:  2018-09-18       Impact factor: 4.307

7.  The Expression of Activating Receptor Gene of Natural Killer Cells (KLRC3) in Patients with 
Type 1 Diabetes Mellitus (T1DM).

Authors:  Dalia Shalaby; Marwa Saied; Doaa Khater; Abla Abou Zeid
Journal:  Oman Med J       Date:  2017-07

Review 8.  Designing a bioelectronic treatment for Type 1 diabetes: targeted parasympathetic modulation of insulin secretion.

Authors:  Elliott W Dirr; Morgan E Urdaneta; Yogi Patel; Richard D Johnson; Martha Campbell-Thompson; Kevin J Otto
Journal:  Bioelectron Med (Lond)       Date:  2020-07-28

9.  Type 1 Diabetes Mellitus Donor Mesenchymal Stromal Cells Exhibit Comparable Potency to Healthy Controls In Vitro.

Authors:  Lindsay C Davies; Jessica J Alm; Nina Heldring; Guido Moll; Caroline Gavin; Ioannis Batsis; Hong Qian; Mikael Sigvardsson; Bo Nilsson; Lauri E Kyllonen; Kaija T Salmela; Per-Ola Carlsson; Olle Korsgren; Katarina Le Blanc
Journal:  Stem Cells Transl Med       Date:  2016-07-13       Impact factor: 6.940

10.  Healthy Donor Polyclonal IgMs Diminish B-Lymphocyte Autoreactivity, Enhance Regulatory T-Cell Generation, and Reverse Type 1 Diabetes in NOD Mice.

Authors:  Christopher S Wilson; Preeti Chhabra; Andrew F Marshall; Caleigh V Morr; Blair T Stocks; Emilee M Hoopes; Rachel H Bonami; Greg Poffenberger; Kenneth L Brayman; Daniel J Moore
Journal:  Diabetes       Date:  2018-08-21       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.